Cancer Patients Develop 'Adequate' Immune Response to COVID Vax

(MedPage Today) -- The vast majority of patients undergoing active systemic therapy for cancer exhibited an adequate immune response to the Pfizer/BioNTech COVID-19 vaccine, according to a prospective cohort study.
A total of 90% of patients with...